BMO Capital Markets set a $25.00 target price on HCP (NYSE:HCP) in a report released on Monday. The firm currently has a hold rating on the real estate investment trust’s stock.

HCP has been the subject of several other research reports. KeyCorp reiterated a hold rating on shares of HCP in a research report on Sunday, September 17th. Zacks Investment Research cut HCP from a hold rating to a sell rating in a research report on Tuesday, January 2nd. JPMorgan Chase & Co. upgraded HCP from a neutral rating to an overweight rating and set a $29.00 price target for the company in a research report on Friday, December 15th. Mizuho upgraded HCP from a neutral rating to a buy rating and set a $32.00 price target for the company in a research report on Thursday, November 2nd. Finally, ValuEngine cut HCP from a buy rating to a hold rating in a research report on Sunday, December 31st. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus price target of $30.14.

HCP (NYSE HCP) opened at $23.72 on Monday. The stock has a market capitalization of $11,130.00, a price-to-earnings ratio of 42.36, a price-to-earnings-growth ratio of 2.64 and a beta of 0.33. The company has a debt-to-equity ratio of 1.17, a current ratio of 0.61 and a quick ratio of 0.61. HCP has a 52-week low of $23.49 and a 52-week high of $33.67.

HCP (NYSE:HCP) last released its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.46 by $0.02. The firm had revenue of $454.00 million during the quarter, compared to analysts’ expectations of $440.60 million. HCP had a return on equity of 8.85% and a net margin of 27.31%. HCP’s revenue was down 14.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.72 earnings per share. equities analysts expect that HCP will post 1.94 EPS for the current fiscal year.

Several hedge funds have recently made changes to their positions in HCP. Schwab Charles Investment Management Inc. boosted its stake in shares of HCP by 5.1% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 4,459,500 shares of the real estate investment trust’s stock valued at $116,304,000 after acquiring an additional 216,962 shares during the last quarter. Creative Planning boosted its stake in shares of HCP by 34.9% during the fourth quarter. Creative Planning now owns 81,094 shares of the real estate investment trust’s stock valued at $2,115,000 after acquiring an additional 20,985 shares during the last quarter. National Pension Service boosted its stake in shares of HCP by 14.5% during the fourth quarter. National Pension Service now owns 554,076 shares of the real estate investment trust’s stock valued at $14,450,000 after acquiring an additional 70,261 shares during the last quarter. BerganKDV Wealth Management LLC boosted its stake in shares of HCP by 4.2% during the fourth quarter. BerganKDV Wealth Management LLC now owns 51,797 shares of the real estate investment trust’s stock valued at $1,351,000 after acquiring an additional 2,110 shares during the last quarter. Finally, Bank of Montreal Can boosted its stake in shares of HCP by 13.3% during the fourth quarter. Bank of Montreal Can now owns 406,731 shares of the real estate investment trust’s stock valued at $10,608,000 after acquiring an additional 47,692 shares during the last quarter. Institutional investors and hedge funds own 90.07% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “BMO Capital Markets Analysts Give HCP (HCP) a $25.00 Price Target” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/bmo-capital-markets-analysts-give-hcp-hcp-a-25-00-price-target/1811542.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.